Sign up
Healthed-White-on-Blue

Diabetes and metabolism

2320123765
A/Prof Ralph Audehm
Podcasts iconPodcasts

Chronic kidney disease in diabetes: What clinicians need to check early – Panel

A practical, case-based panel i showing how kidney, cardiovascular and metabolic risks intersect in diabetes, and how current therapies can be combined for meaningful long term benefit.

Expert/s: A/Prof Ralph Audehm, Prof Eugenia Pedagogos, Prof Richard MacIsaac
CKD
Prof Eugenia Pedagogos
Podcasts iconPodcasts

From screening to action: Practical CKD tips for healthcare professionals – Panel

Hear about why urine ACR is critical, the hidden risks of CKD Stage 3A, and how new therapies like SGLT2 inhibitors and GLP-1 receptor agonists are changing care - even beyond diabetes.

Expert/s: Prof Eugenia Pedagogos, Prof Richard MacIsaac, A/Prof Ralph Audehm
A,Doctor,Uses,An,Anatomical,Kidney,Model,To,Explain,Renal
Prof Merlin Thomas
Podcasts iconPodcasts

SGLT2s and renal protection

Understand CKD screening priorities, risk mitigation strategies, and the role of SGLT-2 inhibitors in preventing progression and complications.

Expert/s: Prof Merlin Thomas
Kidney,Diseases.,Man,Suffering,From,Pain,With,Inflammation,And,Kidney
Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Podcasts iconPodcasts

Panel discussion on GLP1s for chronic kidney disease in type 2 diabetes

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

Expert/s: Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Macrae, Finlay AO (2)
Prof Finlay Macrae AO
Videos iconVideos

Management of a gluten free diet with GluteGuard

In this Product Explainer, Gastroenterologist Prof Finlay Macrae AO explains the common challenges when following a strict gluten free diet and the role of enzyme supplementation with GluteGuard.

Expert/s: Prof Finlay Macrae AO
Overweight,Woman,Having,Consultation,At,Doctor's,Office
A/Prof Samantha Hocking
Clinical Articles iconClinical Articles

Tirzepatide vs semaglutide: A head-to-head comparison for management of obesity

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

Expert/s: A/Prof Samantha Hocking
Diabetes,Monitor,,Cholesterol,Diet,And,Healthy,Food,Eating,Nutrition,,World
Dr Ted Wu
Podcasts iconPodcasts

Cardiovascular outcomes & GLP1 – An update

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu
diabetes, exercise
A/Prof Spiros Fourlanos & Samantha Stuk
Podcasts iconPodcasts

Maintaining muscle mass & nutritional status while losing weight on GLP-1RAs

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Expert/s: A/Prof Spiros Fourlanos & Samantha Stuk
shutterstock_2307935835
A/Prof Craig Beall
Clinical Articles iconClinical Articles

Ten ways diabetes and dementia are linked

New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

Expert/s: A/Prof Craig Beall, Natasha MacDonald
Course image - GLP1s in T2D related kidney disease - Novo nordisk
Prof Vlado Perkovic
Videos iconVideos

The role of GLP-1s in type 2 diabetes-related kidney disease

Discover the latest evidence behind semaglutide 1.0mg's recent CKD indication in T2D and its impact on everyday practice.

Expert/s: Prof Vlado Perkovic
1648282072
Dr Melissa Beitner
Podcasts iconPodcasts

Obesity as a chronic disease: Rethinking assessment and escalation of care

Dr Melissa Beitner discusses how to approach obesity as a chronic disease, providing clear insights on assessment, treatment options, and the GP’s role in long-term patient support.

Expert/s: Dr Melissa Beitner
Cardiovascular benefits for GLP1s - Novo Nordisk_Smaller
Dr Adam Nelson
Videos iconVideos

Cardiovascular benefits of GLP-1s – New evidence

Discover how semaglutide 2.4mg aligns with best practice cardiac care guidelines.

Expert/s: Dr Adam Nelson

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform